NEUTROPHIL-RICH, KI-1-POSITIVE ANAPLASTIC LARGE-CELL MALIGNANT-LYMPHOMA

被引:100
作者
MANN, KP
HALL, B
KAMINO, H
BOROWITZ, MJ
RATECH, H
机构
[1] MONTEFIORE MED CTR, BRONX, NY 10467 USA
[2] DUKE UNIV, MED CTR, DEPT PATHOL, DURHAM, NC USA
[3] NYU, MED CTR, DERMATOPATHOL SECT, NEW YORK, NY 10016 USA
[4] ALBERT EINSTEIN COLL MED, DEPT PATHOL, BRONX, NY 10467 USA
关键词
KI-1; CD30; ANAPLASTIC LARGE-CELL LYMPHOMA; NEUTROPHILS; HUMAN IMMUNODEFICIENCY VIRUS;
D O I
10.1097/00000478-199504000-00002
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
The presence of neutrophils, in the absence of necrosis, is uncommon in malignant lymphoma (ML). We identified a subgroup of Ki-1-positive anaplastic large cell ML (Ki-1 ALCL) in which neutrophils were a prominent component. Six of 20 cases of Ki-1 ALCL had a significant neutrophil infiltrate that varied from 5 to 10% to >50% of cells per high power field. Neutrophils were not seen in 100 cases of other types of ML reviewed. Patients were first seen with skin lesions (four), localized lymphadenopathy (three), generalized lymphadenopathy (one), and localized extranodal disease (one). All had primary disease. Two patients had peripheral neutrophilia. Three of six patients had clinical stage IV disease. Four patients are currently in clinical remission; one died of recurrent disease; and one patient with acquired immunodeficiency syndrome (AIDS) died of Pneumocystis carinii pneumonia. Four cases demonstrated a T-cell phenotype, one of which arose in a patient with AIDS. Two had a B-cell phenotype. All cases were positive for CD30 (Ki-1). These observations expand the morphologic spectrum of Ki-1 ALCL to include a neutrophil-rich variant. We conclude that the presence of neutrophils is another morphologic feature shared by some cases of Ki-1 ALCL, lymphomatoid papulosis, and Hodgkin's disease, which suggests a possible pathogenetic link among them.
引用
收藏
页码:407 / 416
页数:10
相关论文
共 85 条
[41]  
KINNEY MC, 1991, PATHOL ANNU, V26, P1
[42]   LYMPHOID NEOPLASIA ASSOCIATED WITH THE ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS) - THE NEW-YORK-UNIVERSITY-MEDICAL-CENTER EXPERIENCE WITH 105 PATIENTS (1981-1986) [J].
KNOWLES, DM ;
CHAMULAK, GA ;
SUBAR, M ;
BURKE, JS ;
DUGAN, M ;
WERNZ, J ;
SLYWOTZKY, C ;
PELICCI, PG ;
DALLAFAVERA, R ;
RAPHAEL, B .
ANNALS OF INTERNAL MEDICINE, 1988, 108 (05) :744-753
[43]   PRODUCTION OF MONOCYTE CHEMOTACTIC AND ACTIVATING FACTOR (MCAF) BY HUMAN DERMAL FIBROBLASTS IN RESPONSE TO INTERLEUKIN-1 OR TUMOR NECROSIS FACTOR [J].
LARSEN, CG ;
ZACHARIAE, COC ;
OPPENHEIM, JJ ;
MATSUSHIMA, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1989, 160 (03) :1403-1408
[44]  
LARSEN CG, 1989, IMMUNOLOGY, V68, P31
[45]   THE NEUTROPHIL-ACTIVATING PROTEIN (NAP-1) IS ALSO CHEMOTACTIC FOR LYMPHOCYTES-T [J].
LARSEN, CG ;
ANDERSON, AO ;
APPELLA, E ;
OPPENHEIM, JJ ;
MATSUSHIMA, K .
SCIENCE, 1989, 243 (4897) :1464-1466
[46]  
LEONCINI L, 1990, AM J PATHOL, V137, P1047
[47]  
LEVINE AM, 1992, BLOOD, V80, P8
[48]  
LOWENTHAL DA, 1988, CANCER, V61, P2325, DOI 10.1002/1097-0142(19880601)61:11<2325::AID-CNCR2820611130>3.0.CO
[49]  
2-0
[50]   MOLECULAR-CLONING OF A HUMAN MONOCYTE-DERIVED NEUTROPHIL CHEMOTACTIC FACTOR (MDNCF) AND THE INDUCTION OF MDNCF MESSENGER-RNA BY INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR [J].
MATSUSHIMA, K ;
MORISHITA, K ;
YOSHIMURA, T ;
LAVU, S ;
KOBAYASHI, Y ;
LEW, W ;
APPELLA, E ;
KUNG, HF ;
LEONARD, EJ ;
OPPENHEIM, JJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (06) :1883-1893